Custom synthesis | Naphthyridine | Pyrimidine | Indoline |
Peptides

Pramlintide Acetate 196078-30-5

Pramlintide Acetate 196078-30-5

Pramlintide is a relatively new injectable drug for diabetes (both type 1 and 2), developed by Amylin Pharmaceuticals (now a wholly owned subsidiary of AstraZeneca).Pramlintide is sold as an acetate salt.

GMP for Pramlintide Acetate 196078-30-5 is not available.
 
Disclaimer:Those products (Pramlintide Acetate 196078-30-5) are for lab analytical & research purposes only.